Author: PharmaSignal News Desk

Eli Lilly $1 Trillion market value milestone achieved through obesity drug success, surpassing peers.

Pfizer settlement Texas involves $41.5 million payment over ADHD drug manufacturing flaws.

FDA quick clarifications allow biotechs to email agency staff, enhancing communication and expediting drug development processes.

Pfizer settlement Texas involves $41.5 million over allegations of altered testing methods for an ADHD drug.

Contineum MS trial failure leads to a significant share drop, affecting Johnson & Johnson’s interest.

Novo Nordisk is set to release pivotal Phase 3 data on semaglutide’s impact on Alzheimer’s, potentially reshaping treatment.

Novo Nordisk is set to reveal results of its semaglutide study for Alzheimer’s, potentially expanding its indications.

Novo Nordisk Ozempic discount at $199 boosts telehealth partnerships, increasing drug access and sales.

RFK Jr. profile reveals insights into his health policy stance, impacting millions of Americans.

Moderna $1.5B investment aims to expand its vaccine franchise and achieve breakeven by 2028.